TY - JOUR
T1 - The Translational Bridge between Inflammation and Hepatocarcinogenesis
AU - Gufler, Sabine
AU - Seeboeck, Rita
AU - Schatz, Christoph
AU - Haybaeck, Johannes
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Viral infections or persistent alcohol or drug abuse, together with intrinsic factors, lead to hepatitis, which often ends in the development of liver cirrhosis or hepatocellular carcinoma (HCC). With this review, we describe inflammatory liver diseases, such as acute liver failure, virus-induced hepatitis, alcoholic- and non-alcoholic steatohepatitis, and autoimmune hepatitis, and highlight their driving mechanisms. These include external factors such as alcohol misuse, viral infection and supernutrition, as well as intrinsic parameters such as genetic disposition and failure, in immune tolerance. Additionally, we describe what is known about the translational machinery within all these diseases. Distinct eukaryotic translation initiation factors (eIFs) with specific functional roles and aberrant expression in HCC are reported. Many alterations to the translational machinery are already triggered in the precancerous lesions described in this review, highlighting mTOR pathway proteins and eIFs to emphasize their putative clinical relevance. Here, we identified a lack of knowledge regarding the roles of single eIF proteins. A closer investigation will help to understand and treat HCC as well as the antecedent diseases.
AB - Viral infections or persistent alcohol or drug abuse, together with intrinsic factors, lead to hepatitis, which often ends in the development of liver cirrhosis or hepatocellular carcinoma (HCC). With this review, we describe inflammatory liver diseases, such as acute liver failure, virus-induced hepatitis, alcoholic- and non-alcoholic steatohepatitis, and autoimmune hepatitis, and highlight their driving mechanisms. These include external factors such as alcohol misuse, viral infection and supernutrition, as well as intrinsic parameters such as genetic disposition and failure, in immune tolerance. Additionally, we describe what is known about the translational machinery within all these diseases. Distinct eukaryotic translation initiation factors (eIFs) with specific functional roles and aberrant expression in HCC are reported. Many alterations to the translational machinery are already triggered in the precancerous lesions described in this review, highlighting mTOR pathway proteins and eIFs to emphasize their putative clinical relevance. Here, we identified a lack of knowledge regarding the roles of single eIF proteins. A closer investigation will help to understand and treat HCC as well as the antecedent diseases.
KW - Carcinogenesis
KW - Carcinoma, Hepatocellular/genetics
KW - Ethanol
KW - Hepatitis, Viral, Human
KW - Humans
KW - Inflammation
KW - Liver Cirrhosis
KW - Liver Neoplasms/genetics
KW - Non-alcoholic Fatty Liver Disease
KW - TOR Serine-Threonine Kinases
UR - http://www.scopus.com/inward/record.url?scp=85123892721&partnerID=8YFLogxK
U2 - 10.3390/cells11030533
DO - 10.3390/cells11030533
M3 - Review article
C2 - 35159342
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
IS - 3
M1 - 533
ER -